Skip to main content

Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)

This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

 
Catalog of Federal Domestic Assistance Number: 93.393
Sponsors
National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
Deadlines
Letter of Intent (Optional): May 7, 2020
Application: Jun 7, 2020
Contact

Scientific/research contact:
Joanne Elena, Ph.D., M.P.H.
240.276.6818
elenajw@mail.nih.gov

Peer review contact:
Referral Officer, National Cancer Institute
240.276.6390
ncirefof@dea.nci.nih.gov

Financial and grants management contact:
Crystal Wolfrey
240.276.6277
wolfreyc@mail.nih.gov

Purpose

This program provides funding to support research in new and innovative cohort studies that identify clinical, lifestyle, genomic, and other factors that affect health outcomes in cancer survivors from diagnosis to the end of life. Outcomes may include morbidity, mortality, quality of life, physical, social, and psychological outcomes.

Research questions of interest include:

  • What are the long-term outcomes for emerging, novel, and combination cancer therapies and how do they differ among populations?
  • How are obesity, physical activity, inflammation-related pathways, and lifestyle factors related to cancer progression, recurrence, subsequent incident cancers, and mortality among understudied adult cancer survivors?
  • How are physical, psychological, social, financial, and quality of life factors associated with survival and/or morbidity across various geographic areas (rural, urban), socioeconomic status, or by race/ethnicity or gender?
  • How do cancer and its treatment alter aging trajectories among adult cancer survivors?
  • What clinical, genomic, and lifestyle factors influence long-term treatment outcomes and adverse events in chronic cancer therapy for survivors with metastatic disease?
Eligibility

Eligible applicants include:

  • Higher education institutions
    • Public/state controlled institutions
    • Private institutions
  • Nonprofit organizations
    • With 501(c)(3) status
    • Without 501(c)(3) status
    • Native American tribal organizations
    • Faith-based or community-based organizations
    • Regional organizations
  • Governments
    • State
    • County
    • City or township
    • Special districts
    • Federally recognized Indian/Native American tribal governments
    • Indian/Native American tribal governments (other than federally recognized)
    • Eligible agencies of the federal government
    • U.S. territory or possession
  • Other
    • Independent school districts
    • Public housing authorities
    • Indian housing authorities
    • Non-domestic entities and non-domestic components of U.S. entities
    • Small businesses
    • For-profit organizations
Geographic coverage
Nationwide and U.S. territories
Amount of funding

Application budgets are limited to $750,000 direct costs per year in years 1 and 2. Budgets in years 3-6 are not limited but must reflect the actual needs of the proposed project.

National Cancer Institute intends to make 3 awards.

Application process

Links to the full announcement, application instructions, and the online application process are available through grants.gov.

While not required, potential applicants are encouraged to email a letter of intent to Joanne Elena, Ph.D., M.P.H. by May 7, 2020.

Tagged as
Cancer ยท Research methods and resources



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.